Viewing StudyNCT04667975



Ignite Creation Date: 2024-05-06 @ 3:32 PM
Last Modification Date: 2025-12-17 @ 7:01 PM
Study NCT ID: NCT04667975
Status: None
Last Update Posted: 2020-12-16 00:00:00
First Post: 2020-09-29 00:00:00

Brief Title: The Purpose of Study is to Evaluate the Safety, Pharmacokinetics and Anti-tumor Effects of CKD-702 in Patients With Advanced or Metastatic Non-small Cell Lung Cancer Who Failed to Standard Therapy
Sponsor: Chong Kun Dang Pharmaceutical
Organization: Chong Kun Dang Pharmaceutical

Key Dates - Follows AllAPIJSON File Order

Start Date: 2020-05-21
Start Date Type: ACTUAL
Primary Completion Date: 2021-08-15
Primary Completion Date Type: ESTIMATED
Completion Date: 2024-08-30
Completion Date Type: ESTIMATED
First Submit Date: 2020-09-29 00:00:00
First Submit QC Date: December 11 2020
Study First Post Date: 2020-12-16
Study First Post Date Type: ACTUAL
Results First Submit Date: None
Results First Submit QC Date: None
Results First Post Date: None
Results First Post Date Type: None
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2020-12-11 00:00:00
Last Update Post Date: 2020-12-16 00:00:00
Last Update Post Date Type: ACTUAL